Literature DB >> 6190815

Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor.

N A Nicola, D Metcalf, M Matsumoto, G R Johnson.   

Abstract

A naturally occurring inducer of terminal differentiation in a murine myelomonocytic leukemia cell line (WEHI-3B) was purified to apparent homogeneity from medium conditioned by lungs from mice injected with bacterial endotoxin. The factor was purified over 400,000-fold by sequential fractionation using salting out chromatography, chromatography on phenyl-Sepharose, gel filtration on Bio-Gel P-60 in 1 M acetic acid, reverse-phase high performance liquid chromatography on a phenyl-silica column, and high performance liquid chromatography on a gel filtration column. During the first two steps, the differentiation-inducing factor was separated completely from a known proliferative regulator for normal myeloid cells, granulocyte-macrophage colony-stimulating factor, but it co-purified through all remaining steps with a distinct granulocyte-specific colony-stimulating factor. The purified factor showed a single protein band of Mr = 24,000-25,000 on sodium dodecyl sulfate-polyacrylamide gels coincident with both differentiation-inducing and granulocyte colony-stimulating activity. The granulocyte-specific colony-stimulating factor was active on WEHI-3B cells and normal granulocytic progenitor cells in vitro at the same half-maximally active concentration of 3 X 10(-12) M.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190815

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  96 in total

1.  Neuroprotective therapy using granulocyte colony-stimulating factor for patients with worsening symptoms of compression myelopathy, Part 1: a phase I and IIa clinical trial.

Authors:  Tsuyoshi Sakuma; Masashi Yamazaki; Akihiko Okawa; Hiroshi Takahashi; Kei Kato; Mitsuhiro Hashimoto; Koichi Hayashi; Takeo Furuya; Takayuki Fujiyoshi; Junko Kawabe; Chikato Mannoji; Ryo Kadota; Masayuki Hashimoto; Kazuhisa Takahashi; Masao Koda
Journal:  Eur Spine J       Date:  2011-09-21       Impact factor: 3.134

2.  Granulocyte colony-stimulating factor (G-CSF) production by astrocytoma cells and its effect on tumor growth.

Authors:  T Kikuchi; S Nakahara; T Abe
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

3.  Recombinant filgrastim (BK0023) pharmacodynamics and pharmacokinetics after single and multiple escalating doses in an equivalence study in healthy men.

Authors:  Andrea F D Di Stefano; Gaia Spinetti; Antonio Rusca; Milko M Radicioni; Luca Loprete; Domenica M G Lamparelli; Jutta Michael Hepp; Davide Crobu; Rodolfo Schrepfer; Giancarlo Tonon
Journal:  Clin Drug Investig       Date:  2015-09       Impact factor: 2.859

4.  Acetylation impacts Fli-1-driven regulation of granulocyte colony stimulating factor.

Authors:  Mara L Lennard Richard; Danielle Brandon; Ning Lou; Shuzo Sato; Tomika Caldwell; Tamara K Nowling; Gary Gilkeson; Xian K Zhang
Journal:  Eur J Immunol       Date:  2016-08-16       Impact factor: 5.532

Review 5.  Hematopoietic cytokines.

Authors:  Donald Metcalf
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

Review 6.  Following the cytokine signaling pathway to leukemogenesis: a chronology.

Authors:  Kendall A Smith; James D Griffin
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

7.  The zebrafish granulocyte colony-stimulating factors (Gcsfs): 2 paralogous cytokines and their roles in hematopoietic development and maintenance.

Authors:  David L Stachura; Ondrej Svoboda; Clyde A Campbell; Raquel Espín-Palazón; Ryan P Lau; Leonard I Zon; Petr Bartunek; David Traver
Journal:  Blood       Date:  2013-10-15       Impact factor: 22.113

8.  Production of autostimulatory growth factors by the human carcinoma line, RPMI 2650.

Authors:  B M Carey; M Dooley; R Weedle; M Clynes
Journal:  In Vitro Cell Dev Biol       Date:  1993-02

Review 9.  The colony-stimulating factors and cancer.

Authors:  Donald Metcalf
Journal:  Cancer Immunol Res       Date:  2013-12       Impact factor: 11.151

Review 10.  Heterogeneity of human colon carcinoma.

Authors:  M G Brattain; A E Levine; S Chakrabarty; L C Yeoman; J K Willson; B Long
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.